What is COSENTYX ?
COSENTYX is a different kind of targeted biologic. It's the first of its kind to target IL-17A. COSENTYX treats multiple symptoms of psoriatic arthritis, such as joint pain and swelling, enthesitis pain, dactylitis, and psoriasis skin plaques. It even helps stop further joint damage.† Learn more.
†Based on X-rays of the hands and feet at 6 months.
How long has COSENTYX been on the market?
COSENTYX was approved by the FDA in January 2015 to treat moderate to severe plaque psoriasis, and in January 2016 to treat active psoriatic arthritis and active ankylosing spondylitis. COSENTYX has already been prescribed to over 115,000 people in the United States.‡
COSENTYX has been studied extensively for 12 years in dozens of clinical trials. More clinical trials are still ongoing as we stay committed to studying COSENTYX for people with PsO, PsA, and AS.
‡Across all indications.
What makes COSENTYX different?
COSENTYX is a different kind of targeted biologic. It’s the first and most commonly prescribed treatment of its kind§ and works within your body to target the IL-17A protein, which is thought to play a role in causing inflammation.
“We know there are multiple pathways and multiple proteins involved in inflammation. IL-17A is one of these proteins that could be overproduced in plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. COSENTYX specifically targets IL-17A. Because it’s this specific pathway, that’s the reason it may be different from most other biologics.”
—Dr. Elizabeth Perkins, a Practicing Rheumatologist
§Most prescribed IL-17A treatment across all indications.
How do I take COSENTYX?
COSENTYX is taken by injection, either with the Sensoready® Pen device or a prefilled syringe. Your doctor will show you how to take your medication. To help you feel more comfortable or for an injection refresher, make sure to check out the helpful videos and tools below.
Download the Sensoready Pen quick tips brochure so you have it handy.
How do I inject?
A healthcare provider will show you how to prepare and inject COSENTYX properly before you use it for the first time. If you need a refresher, you can watch our injection demonstration videos or sign up for live virtual injection training by calling 1-844-COSENTYX (1-844-267-3689).
You can also download the Sensoready Pen quick tips brochure so you have it handy.
What’s the dosing?
COSENTYX is a convenient once-a-month dose.
If you have psoriatic arthritis with moderate to severe plaque psoriasis, your doctor may prescribe 5 weekly doses to start, followed by one dose every 4 weeks. The recommended dose is 300 mg, which is taken as two (2) 150-mg injections under the skin. For some people, a dose of 150 mg may be acceptable.
If you have psoriatic arthritis with mild or no plaque psoriasis, your doctor will either prescribe 5 weekly doses or just one dose once a month to start. After that, you only need to take COSENTYX once every 4 weeks. The recommended dose is 150 mg, which is taken as one injection under the skin.
Find out more about dosing for psoriatic arthritis.
What are the most common side effects?
The most common side effects may include: cold symptoms, diarrhea, nausea, and upper respiratory infections. Keep in mind, these are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects. Here’s additional information about safety for COSENTYX.
How well will it work?
Individual results may vary. In the largest clinical trial ever conducted for psoriatic arthritis, up to 60% of patients saw at least a 20% improvement in PsA symptoms at 16 weeks, with some patients feeling relief as early as 3 weeks.‖
‖Approximately 60% of patients taking COSENTYX saw this level of improvement at 16 weeks versus 18% of patients taking placebo.
When will it start working?
Individual results may vary. Up to 60% of patients in a clinical study saw at least a 20% improvement in PsA symptoms at 16 weeks,¶ with some patients feeling relief as early as 3 weeks. Learn more about how COSENTYX works for psoriatic arthritis.
¶Versus 18% of patients taking placebo.
What is the COSENTYX® Connect Personal Support Program?
COSENTYX® Connect is a free dedicated support program for everyone taking COSENTYX, or for those who want to learn more about COSENTYX. When you sign up, you’ll be able to take advantage of the great tools and resources available exclusively through COSENTYX® Connect.
For those who are prescribed COSENTYX, these benefits include:
- A dedicated support specialist to help you understand your insurance coverage and what your out-of-pocket costs might be, set up your $0 co-pay,* and check in from time to time throughout your first year of treatment
- $0 co-pay* if you’re eligible
- Up to two years of free medication, while you work with your commercial health plan to secure coverage for COSENTYX# Learn more
- A Welcome Kit with tools, including a travel kit, and other resources to help you get started
- A recyclable sharps container
- Injection training support
- Personalized support and resources via mail, e-mail, or text
- Consumer Brief Summary of Important Safety Information
Will my insurance cover it?
If you have commercial insurance, COSENTYX® Connect or your specialty pharmacy will conduct a benefits investigation to see whether your insurance covers COSENTYX and what your out-of-pocket costs might be.
If you have commercial or private insurance, and your coverage is initially denied, you may get up to 2 years of COSENTYX for free through COSENTYX® Connect while you continue to work with your insurance company to resubmit for coverage.
Questions? Please call us at 1-844-COSENTYX (1-844-267-3689) or download the Insurance Coverage Questions brochure.
What if I don’t qualify for the $0 co-pay* or the Covered Until You’re Covered Program#?
Visit Novartis Patient Assistance NOW to get assistance with finding programs that may help you with your Novartis prescription medications. Learn more at www.patientassistancenow.com or by calling 1-800-277-2254.
*Limitations apply. Up to a $16,000 annual limit. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.
#Covered Until You're Covered Program: Eligible patients must have commercial insurance, a valid prescription for COSENTYX, and a denial of insurance coverage based on a prior authorization request. Program requires the submission of an appeal of the coverage denial within the first 90 days of enrollment in order to remain eligible. Program provides initial 5 weekly doses (if prescribed) and monthly doses for free to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to re-verify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a limited Program extension. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice. Program enrollment must occur by 12/31/19.